Skip to main content
. 2019;20(11):3521–3525. doi: 10.31557/APJCP.2019.20.11.3521

Figure 1.

Figure 1

COX-2 Immunostaining Images. COX-2 expression in breast cancer patients (n=100) tissues was assessed by immunohistochemistry (A) Low COX-2 expression was observed in ductal carcinoma. (B) High COX-2 expression was detected in invasive ductal carcinoma. The staining was cytoplasmic. Images were captured at x 40 magnification